BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

792 related articles for article (PubMed ID: 32015683)

  • 21. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
    Zhang Y; Zhang Y; Yin Y; Li S
    Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated plasma and exosome long noncoding RNA profiling is promising for diagnosing non-small cell lung cancer.
    Wang N; Yao C; Luo C; Liu S; Wu L; Hu W; Zhang Q; Rong Y; Yuan C; Wang F
    Clin Chem Lab Med; 2023 Nov; 61(12):2216-2228. PubMed ID: 37387637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal Long Non-Coding RNAs in Lung Diseases.
    Poulet C; Njock MS; Moermans C; Louis E; Louis R; Malaise M; Guiot J
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32438606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer.
    Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C
    Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum exosomal long noncoding RNAs as a diagnostic biomarker for atrial fibrillation.
    Kang JY; Mun D; Kim H; Yun N; Joung B
    Heart Rhythm; 2022 Sep; 19(9):1450-1458. PubMed ID: 35660473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer.
    Liu W; Liu J; Zhang Q; Wei L
    Cancer Biomark; 2020; 27(1):113-120. PubMed ID: 31771047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. M2 macrophage-derived exosomal long non-coding RNA AGAP2-AS1 enhances radiotherapy immunity in lung cancer by reducing microRNA-296 and elevating NOTCH2.
    Zhang F; Sang Y; Chen D; Wu X; Wang X; Yang W; Chen Y
    Cell Death Dis; 2021 May; 12(5):467. PubMed ID: 33972506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of an Exosomal Long Noncoding RNA SOX2-OT in Plasma as a Promising Biomarker for Lung Squamous Cell Carcinoma.
    Teng Y; Kang H; Chu Y
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):235-240. PubMed ID: 30986097
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expressions and potential clinical values of lncRNAs in the plasma exosomes of rheumatoid arthritis.
    Shuai ZQ; Wang ZX; Ren JL; Yang XK; Xu B
    Int Immunopharmacol; 2024 Feb; 128():111511. PubMed ID: 38194746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma Exosomal Long Non-Coding RNAs Serve as Biomarkers for Early Detection of Colorectal Cancer.
    Hu D; Zhan Y; Zhu K; Bai M; Han J; Si Y; Zhang H; Kong D
    Cell Physiol Biochem; 2018; 51(6):2704-2715. PubMed ID: 30562751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
    Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
    Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
    Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-derived exosomal proteins as diagnostic biomarkers in non-small cell lung cancer.
    Niu L; Song X; Wang N; Xue L; Song X; Xie L
    Cancer Sci; 2019 Jan; 110(1):433-442. PubMed ID: 30407700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression analysis of vimentin and the related lncRNA network in breast cancer.
    Mohebi M; Ghafouri-Fard S; Modarressi MH; Dashti S; Zekri A; Kholghi-Oskooei V; Taheri M
    Exp Mol Pathol; 2020 Aug; 115():104439. PubMed ID: 32283061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating long non-coding RNA GAS5 and SOX2OT as potential biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Kamel LM; Atef DM; Mackawy AMH; Shalaby SM; Abdelraheim N
    Biotechnol Appl Biochem; 2019 Jul; 66(4):634-642. PubMed ID: 31077615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three circulating long non-coding RNAs act as biomarkers for predicting NSCLC.
    Tang Q; Ni Z; Cheng Z; Xu J; Yu H; Yin P
    Cell Physiol Biochem; 2015; 37(3):1002-9. PubMed ID: 26393913
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
    Zhang Y; Xu H
    J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PLA2G10 incorporated in exosomes could be diagnostic and prognostic biomarker for non-small cell lung cancer.
    Chen Y; Ma X; Lou C; Zhou C; Zhao X; Li N; Tian H; Meng X
    Clin Chim Acta; 2022 May; 530():55-65. PubMed ID: 35231479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and Prognostic Potential of Circulating Long Non-Coding RNAs in Non Small Cell Lung Cancer.
    Peng W; Wang J; Shan B; Peng Z; Dong Y; Shi W; He D; Cheng Y; Zhao W; Zhang C; Li B; Duan C
    Cell Physiol Biochem; 2018; 49(2):816-827. PubMed ID: 30165346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.